XTX Topco Ltd Takes $115,000 Position in 908 Devices Inc. (NASDAQ:MASS)

XTX Topco Ltd bought a new position in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 52,196 shares of the company's stock, valued at approximately $115,000. XTX Topco Ltd owned approximately 0.15% of 908 Devices as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of MASS. Bank of Montreal Can purchased a new position in shares of 908 Devices in the fourth quarter worth about $124,000. Geode Capital Management LLC lifted its stake in 908 Devices by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 581,300 shares of the company's stock worth $1,279,000 after purchasing an additional 13,512 shares in the last quarter. Prudential Financial Inc. acquired a new position in shares of 908 Devices during the 4th quarter worth approximately $34,000. LPL Financial LLC grew its position in shares of 908 Devices by 13.0% in the fourth quarter. LPL Financial LLC now owns 63,287 shares of the company's stock valued at $139,000 after purchasing an additional 7,295 shares in the last quarter. Finally, Prescott Group Capital Management L.L.C. acquired a new stake in shares of 908 Devices in the fourth quarter valued at approximately $330,000. Institutional investors and hedge funds own 88.06% of the company's stock.

908 Devices Price Performance

Shares of NASDAQ:MASS traded down $0.11 during midday trading on Monday, reaching $5.49. 55,563 shares of the company's stock were exchanged, compared to its average volume of 983,211. The stock has a market cap of $196.21 million, a price-to-earnings ratio of -3.11 and a beta of 0.26. 908 Devices Inc. has a fifty-two week low of $1.81 and a fifty-two week high of $7.48. The firm's 50 day simple moving average is $4.14 and its two-hundred day simple moving average is $3.15.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Weiss Ratings reissued a "sell (d-)" rating on shares of 908 Devices in a research note on Thursday, April 24th. Stephens reissued an "overweight" rating and issued a $6.00 price objective on shares of 908 Devices in a report on Wednesday, January 15th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $5.33.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.